SEC 13F Intelligence

Managers / Q4 2018 · view latest →

CVI Holdings, LLC

CIK 0001728194 · ONE COMMERCE CENTER, 1201 N. ORANGE STREET, SUITE 715, WILMINGTON, DE, 19801 · 6106172600

Reported Value
$45M
Q4 2018
Positions
42
Filings on Record
25
2019–present window
Filed
Feb 14, 2019
original filing

Summary

Cvi Holdings, LLC reported $45M in U.S.-listed holdings across 42 positions for Q4 2018.

The portfolio is heavily concentrated: MNKD alone accounts for 25.3% of reported value.

Portfolio Metrics

Top-10 Concentration
+92.1%
share of reported value
Largest Position
+25.3%
Mannkind

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $45MQ4 ’18Q1 ’19: $106MQ2 ’19: $172MQ3 ’19: $131MQ3 ’19Q4 ’19: $71MQ1 ’20: $28MQ2 ’20: $270MQ2 ’20Q3 ’20: $246MQ4 ’20: $536MQ1 ’21: $1.4BQ1 ’21Q2 ’21: $1.5BQ3 ’21: $1.6BQ4 ’21: $1.5BQ4 ’21Q1 ’22: $1.5BQ2 ’22: $1.4BQ3 ’22: $1.3BQ3 ’22Q4 ’22: $784MQ1 ’23: $266MQ2 ’23: $95MQ2 ’23Q3 ’23: $51MQ4 ’23: $48MQ1 ’24: $106MQ1 ’24Q2 ’24: $116Mfilingsflow.com

Portfolio Composition

By security type
US DOMESTIC: 47.7%Common Stock: 31.5%Other: 20.8%
  • US DOMESTIC · 47.7% · $21M
  • Common Stock · 31.5% · $14M
  • Other · 20.8% · $9M

Quarter-over-Quarter Changes full breakdown →

IssuerMoveShare ΔShares nowValue ΔValue now
MNKDMANNKIND CORPNEW+10.72M10.72M+$11M$11M
TIMKENSTEEL CORPNEW+10.46M10.46M+$11M$11M
ANI PHARMACEUTICALS INCNEW+9.00M9.00M+$9M$9M
EROS INTL PLCNEW+278.8K278.8K+$2M$2M
SENSEONICS HLDGS INCNEW+1.50M1.50M+$2M$2M
HEAT BIOLOGICS INCNEW+1.56M1.56M+$2M$2M
REXAHN PHARMACEUTICALS INCNEW+1.55M1.55M+$1M$1M
VASCULAR BIOGENICS LTDNEW+1.40M1.40M+$1M$1M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q4 2018

42 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1MNKDMANNKIND CORPhistory →COM NEW25.30%$11M10.72M
2TIMKENSTEEL CORPNOTE 6.000% 6/024.01%$11M10.46M
3ANI PHARMACEUTICALS INCNOTE 3.000%12/020.11%$9M9.00M
4EROS INTL PLCSHS NEW5.15%$2M278.8K
5SENSEONICS HLDGS INCNOTE 5.250% 2/03.61%$2M1.50M
6HEAT BIOLOGICS INCCOM NEW3.40%$2M1.56M
7REXAHN PHARMACEUTICALS INCCOM NEW3.21%$1M1.55M
8VASCULAR BIOGENICS LTDCOM3.03%$1M1.40M
9BBGIEURBEASLEY BROADCAST GROUP INChistory →CL A2.42%$1M290.1K
10VALERITAS HLDGS INCCOM NEW1.85%$832,0002.56M
11AUG1EURAURYN RES INChistory →COM1.49%$670,000732.1K
12VAC2USDVBI VACCINES INChistory →COM NEW1.30%$585,000365.9K
13AXOVANT SCIENCES LTDCOM0.98%$439,000441.1K
14ADVAXIS INCCOM NEW0.93%$417,0002.20M
15AERPIO PHARMACEUTICALS INCCOM0.63%$282,000166.1K
16NVIVDEURINVIVO THERAPEUTICS HLDGS COCOM PAR0.62%$279,000184.7K
17CHINA RECYCLING ENERGY CORPCOM NEW0.38%$172,000232.4K
18NOVN1EURNOVAN INCCOM0.35%$156,000188.5K
19SIGMA LABS INC*W EXP 02/15/2020.17%$78,000200.3K
20SONOMA PHARMACEUTICALS INCCOM0.13%$58,00080.8K
21CHECK CAP LTD*W EXP 05/03/2020.12%$55,000136.4K
22PHIO PHARMACEUTICALS CORPCOM0.11%$51,000155.1K
23AVINGER INCCOM NEW0.10%$44,000146.9K
24SEANERGY MARITIME HLDGS CORP*W EXP 11/10/2020.08%$38,0001.18M
25TONIX PHARMACEUTICALS HLDG CCOM NEW0.08%$36,00016.3K
26SAFE T GROUP LTDSPONSORED ADS0.08%$34,00011.6K
27ELECTRAMECCANICA VEHS CORP*W EXP 08/03/2020.08%$34,00075.3K
28MEDIGUS LTD*W EXP 07/23/2020.07%$32,00064.3K
29BIONDVAX PHARMACEUTICALS LTD*W EXP 05/15/2020.07%$31,00072.8K
30FLEXSHOPPER INC*W EXP 09/28/2020.03%$14,00050.0K
31IMMURON LTD*W EXP 05/12/2020.03%$13,00010.9K
32BENITEC BIOPHARMA LTD*W EXP 08/14/2020.01%$6,00050.0K
33CREATIVE REALITIES INC*W EXP 11/09/2020.01%$6,00015.0K
34AMERI HLDGS INC*W EXP 11/08/2020.01%$5,00099.5K
35ONCONOVA THERAPEUTICS INC*W EXP 07/11/2020.01%$5,000132.2K
36CELLECT BIOTECHNOLOGY LTD*W EXP 08/03/2020.01%$4,00012.5K
37SOLIGENIX INC*W EXP 11/14/2020.01%$4,00016.6K
38CYTORI THERAPEUTICS INC*W EXP 05/28/2020.00%$2,000259.2K
39MYND ANALYTICS INC*W EXP 06/29/2020.00%$1,00013.7K
40INSPIREMD INC*W EXP 03/14/2020.00%$048.0K
41ENERGY FUELS INC*W EXP 09/20/2020.00%$0277.8K
42APPLIED DNA SCIENCES INC*W EXP 11/21/2010.00%$031.4K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q2 2024$116M144Aug 15, 202413F-HRchanges · EDGAR ↗
Q1 2024$106M157May 7, 202413F-HRchanges · EDGAR ↗
Q4 2023$48M187Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$51M229Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$95M277Aug 11, 202313F-HRchanges · EDGAR ↗
Q1 2023$266M413May 16, 202313F-HRchanges · EDGAR ↗
Q4 2022$784M615Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$1.3B882Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$1.4B930Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$1.5B928May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$1.5B948Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$1.6B899Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$1.5B790Aug 11, 202113F-HRchanges · EDGAR ↗
Q1 2021$1.4B615May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$536M182Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$246M83Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$270M70Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$28M37May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$71M36Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019REVEALED$131M107Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019REVEALED$172M118Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$106M58May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$45M42Feb 14, 201913F-HRchanges · EDGAR ↗

Other Included Managers

This filing reports holdings on behalf of 2 additional managers.

  • HEIGHTS CAPITAL MANAGEMENT, INC028-13218
  • CVI Investments, Inc.028-17822

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.